Shenzhen Oculgen Biomedical Technology Co., Ltd.

This study tests a new investigational drug called OCUL101 for people with wet age-related macular degeneration (AMD), a condition that causes vision loss. The drug works by blocking two proteins that damage the eye. About 255 adults aged 50-89 who have not been treated before wi…